Serious re rating candidate in large real estate pan india players, after the successful fund raise. Opens up growth path and Debt levels reduces.
Posts in category Value Pickr
Ranvir’s Portfolio (06-09-2024)
CIPLA –
Q1 FY 25 concall and results highlights –
Revenues – 6694 vs 6329 cr, up 5 pc
Gross Margins @ 67.2 pc – up 226 bps YoY
EBITDA – 1716 vs 1494 cr, up 4 pc ( margins @ 25.5 vs 24 pc )
PAT – 1175 vs 998 cr, up 17 pc
Geography wise sales breakup –
India – 2898 cr, up 5 pc ( trade generics were adversely impacted in Q1 due change in distribution model. Business to be back on growth path wef Q2. Branded prescriptions grew @ a healthy 10 pc – led by respiratory, cardiac and urology therapies )
North America – 2075 cr, up 13 pc ( highest ever Qtly sales ) – Lanreotide 505(b)(2) mkt share @ 20 pc, Albuterol Mkt share @ 17 pc
South Africa branded – 494 cr, up 11 pc ( ranked no-1 in South Africa prescription mkt and no 3 in the OTC mkt ) – launched 8 new products across multiple therapies in Q1
South Africa tender business – 157 vs 101 cr
EM and EU – 846 cr, up 7 pc
APIs – 100 vs 141 cr
R&D expenses @ 354 cr, @ 5.3 pc of sales
Gross Debt @ 547 cr
Cash on Books @ 8996 cr
India – chronic prescription business now @ 61 pc of India sales ( up 100 bps YoY )
Company 24 brands clock sales > 100 cr / yr
Company’s brand – Foracort ( inhaler ) – is ranked no-1 brand in India ( clocking annual sales of 900 cr )
Other mega brands ( sales > 400 cr / yr ) include – URIMAX ( for relief from symptoms of enlarged prostate ) and DYTOR ( diuretic )
Company is also ranked No 1 in trade generics in IPM
Company popular OTC brands in India include – Omnigel, Nicotex, Prolyte, Cofsils, Cipladine
USFDA inspected their facilities at Patalganga and Kurkumbh – and awarded them VAI status. This is good news after successful US FDA inspections at their overseas facilities at China and InnvaGen facility in US
If there was no change in distribution model in the trade generics, India business would have grown by around 9 pc
Company’s India OTC brands are operating at operating 15-16 pc kind of EBITDA margins. Margins should improve as these brands scale up further
Company’s Goa plant was inspected by USFDA in Q1 and was issued with four 483 observations. Its official classification is awaited
Company is working hard on the ramping up of recently acquired Astaberry product portfolio
Revlimid sales were slightly better on a QoQ basis
Resolution of USFDA issue wrt their Goa facility remains a key concern
Seeing an uptick in R&D expenses in next 3 Qtrs of FY 25. For full yr, R&D expenses should settle at 6 pc of sales
Company has lined up launch of 02 peptide products. Same should materialise by Q3/Q4 this yr. In addition, launch of Advair from InvaGen’s manufacturing facility in US should also happen by end of H1 next yr
For the rest of FY, company expects US business’s run rate to be around $ 235-240 million / Qtr
Company is actively looking at both small and big opportunities in the branded generics space in India – for acquisitions – in order to utilise the cash they have on the books. Outside India, they may look at Sterile Injectables or 505(b)(2) product acquisitions in US
Post the launch of 02 peptide products in H2 this yr, company has lined up 03 more peptide product launches for FY 26
Capex guidance / yr @ 1200-1500 cr for next 2-3 yrs
Disc: holding, biased, not SEBI registered, not a buy / sell recommendation
Samhi Hotels – Turnaround with Tailwinds (06-09-2024)
Annual Report Update :- Samhi hotels limited
The company’s management is optimistic about both near-term and long-term growth, underpinned by favorable macroeconomic conditions and robust internal growth strategies. With anticipated improvements in EBITDA margins for same-store assets and the expectation that the ACIC portfolio margins will align with the overall portfolio by the fiscal year’s end, there is confidence in sustainable revenue and EBITDA growth. The company’s net debt stood at ₹1,860 crores as of June 30, 2024, with a cost of debt at 9.7%. Notably, ICRA has upgraded the company’s credit rating to A- stable, signaling an improved capital structure and stronger profitability metrics. There is also an expectation to further reduce the cost of debt below 9.5% through strategic refinancing of high-cost debt, which should support financial flexibility and enhance overall profitability.
Companies With First ever concalls OR Investor Presentations (06-09-2024)
URBAN_06092024131053_Letter_NSE_Investor_presenatation.pdf (6.3 MB)
Urban enviro waste management First investor presentation.
Understanding Thermal Power Producers in under 5 minutes (06-09-2024)
- Power generation companies can be broadly classified as thermal, nuclear, hydro and renewable. Thermal Power Plants are further classified as either coal based or gas based, depending on the fuel used for power generation.
- The thermal power generation in India contributes almost 85 percent of the total energy supply in India.
- In the recent years, capacity utilization of coal based thermal plant has witnessed sizeable improvement owing to sharp increase in peak power demand and less than envisaged renewable generation.
- The Power sector is governed by Central Electricity Regulatory Commission (CERC) at the central Level and various State Electricity Regulatory Commission (SERC) at the state level. The CERC is responsible for determining tariff for the central sector utilities where interstate sale and transmission of power is involved. The SERCs are responsible for framing regulations governing the generation, transmission and distribution of electricity at the state level as well as determining the tariff for state utilities and the tariff payable by the consumer to the distribution utility.
- A power purchase agreement is a crucial document outlining the right and responsibility of the power producer. PPAs can be long term, medium term and short term in nature. Tenor of the contract is crucial element to assess the visibility of the revenue. The revenue and profitability of the project is dependent on the nature of the PPA as well as cost of the fuel. Power off takers(purchasers) are generally state distribution companies, nodal agencies having back to back selling arrangement with discoms and industrial consumers.
- Certain important terms that are crucial to understand PPAs are
- Plant Availability: The percentage of time a power plant is operational and capable of producing electricity over a given period.
- Heat Rate: Heat rate is a measure of the efficiency of a power plant in converting fuel into electricity. It is defined as the amount of energy used by the plant to generate one kilowatt-hour (kWh) of electricity. A lower heat rate indicates a more efficient power plant, as less fuel is needed to produce the same amount of electricity.
- Auxiliary Consumption: Auxiliary consumption refers to the portion of the generated electrical energy that is consumed by the power plant’s auxiliary equipment. Lower auxiliary consumption indicates more of the generated power is available for sale or use on the grid, which improves the overall efficiency of the plant.
- Plant Load Factor (PLF): PLF is a measure of the efficiency and utilization of a power plant. It indicates how well the plant’s capacity is being utilized over a specific period. PLF is expressed as a percentage and is calculated by comparing the actual output of the plant to its maximum possible output over that period.
- The long term PPAs on a cost plus basis are more favourable than long term PPAs on a competitively bid basis followed by medium term and short term PPAs.
- The power projects that sell power on short-term basis at spot tariff rates remain expose to vagaries of price fluctuation and quantum of power off-take and bears the highest sales risk.
- Adequate availability of fuel, coal in case of coal based thermal power plant and natural gas for gas-based station is a crucial factor in assessing the operating capacity of Power projects. Evaluation of fuel supply risk involves source of supply, distance from the source, price and contractual obligation of seller. The power distribution companies (Discoms) are required to procure thermal power based on a merit order despatch,wherein the power plants with the highest variable costs are given least priority. In such a scenario, lower fuel costs ensure higher priority in merit order thereby contributing to higher actual generation.
• Some of the leading thermal power producer companies in India are Tata Power, Adani Power, Reliance Power, NTPC Limited, JSW Energy amongst others.
ValuePickr Surat (06-09-2024)
I’m interested, sent you a DM. thanks!
Va Tech Wabag (06-09-2024)
Yeah, that’s quite big order. It shows Wabag’s credibility amongst the global clients.
Sumit’s Portfolio (06-09-2024)
Thanks for your elaborate answer.
The reason asking for technical analysis is we can get better exit.
Even after so much of detailed analysis, some details will be missed which could impact the returns.
Those details will be known in hindsight. We had number of examples like that. So technicals could give prior indication
What could be your approach if you come to know that something is wrong in the company which you hold?Do you come out of the stock immediatly ? Do you have any such incidents in your journey?
Sumit’s Portfolio (06-09-2024)
Thank you for your kind words.
To address your first question, I don’t practice technical analysis—not because I doubt its usefulness, but simply because I haven’t acquired the technical knowledge needed, nor have I made it a priority to learn. Given my investment horizon of 5-10 years, I believe the impact of technical analysis on my overall returns is likely minimal, which explains my reluctance to dive into it. Additionally, technical analysis tends to emphasize price movements as a guide for investment decisions, rather than focusing on the underlying business fundamentals. This can potentially lead to behaviors that prioritize short-term gains over long-term growth.
As for your second question, I keep my approach broad and open. I discover potential investments from a variety of sources—whether it’s ValuePickr, YouTube videos, screeners, or newspapers. When something catches my attention, I usually take a quick glance at the company’s profile on Screener and review their latest presentations, looking for any red flags that would allow me to dismiss it quickly. Only if I find no significant red flags does the company pique my interest, prompting me to dig deeper. Very few companies meet this stringent criterion, but when they do, I’m willing to expand my circle of competence by studying both the industry and the company more thoroughly—provided the objective criteria align (good management, strong financials, a solid business model, reasonable valuation, and significant growth prospects). In essence, my focus is more on eliminating ideas than selecting them, which means I end up pursuing only those that pass this rigorous filtering process.
Sumit’s Portfolio (06-09-2024)
You’re absolutely right that trusted brands often show a bias toward their own AMCs, creating a potential conflict of interest for clients. This highlights the importance of unbiased wealth management firms that clients can genuinely rely on for their financial needs.
Regarding PMS/AIF players, while they do operate in the wealth management space, they offer a distinct service focused on maximizing returns, often by taking on higher risks. This can be appealing to certain clients, but most HNIs are unlikely to commit 100% of their wealth to such schemes, especially when their primary goal is wealth preservation with minimal risk. PMS/AIFs can certainly play a role in an HNI’s broader investment strategy, but they are unlikely to be the sole focus. Instead of viewing them as direct competition, I see them as complementary offerings that might attract a portion of a client’s wealth, while the majority remains allocated to traditional wealth management firms.